Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Contents
Current Cancer Drug Targets, Volume 20 - Number 10
Review Article
The Roles of Alternative Splicing in Tumor-immune Cell Interactions
, 20(10): 729 - 740Yue Wang, Honglei Zhang*, Baowei Jiao*, Jianyun Nie*, Xiyin Li, Wenhuan Wang and Hairui Wang
DOI: 10.2174/1568009620666200619123725
The Roles of Alternative Splicing in Tumor-immune Cell Interactions
Review Article
Tumor-Induced Metabolism and T Cells Located in Tumor Environment
, 20(10): 741 - 756Sara Iranparast, Sanaz Tayebi, Fatemeh Ahmadpour and Bahman Yousefi*
DOI: 10.2174/1568009620666200720010647
Tumor-Induced Metabolism and T Cells Located in Tumor Environment
Review Article
Regulation of Breast Cancer Progression by Noncoding RNAs
, 20(10): 757 - 767Ravishkumar L. Akshaya, Muthukumar Rohini and Nagarajan Selvamurugan*
DOI: 10.2174/1568009620666200712144103
Regulation of Breast Cancer Progression by Noncoding RNAs
Review Article
Targeting NUPR1 for Cancer Treatment: A Risky Endeavor
, 20(10): 768 - 778Salma M.A. Mansour, Sahar A. Ali, Shaira Nofal and Sameh H. Soror*
DOI: 10.2174/1568009620666200703152523
Targeting NUPR1 for Cancer Treatment: A Risky Endeavor
Review Article
Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling
, 20(10): 779 - 788Wujun Zou*, Xiaoyan Hu and Liang Jiang
DOI: 10.2174/1568009620999200730183631
Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling
Review Article
Molecular Dynamics in Esophageal Adenocarcinoma: Who’s in Control?
, 20(10): 789 - 801Tong Dang and Jianyuan Chai*
DOI: 10.2174/1568009620666200720011341
Molecular Dynamics in Esophageal Adenocarcinoma: Who’s in Control?
Systematic Review Article
Prognostic Value of MiRNAs in Patients with Laryngeal Cancer: A Systematic Review and Meta-Analysis
, 20(10): 802 - 810Wujun Zou, Xiaoyan Hu, Dingting Wang and Liang Jiang*
DOI: 10.2174/1568009620666200806094709
Prognostic Value of MiRNAs in Patients with Laryngeal Cancer: A Systematic Review and Meta-Analysis
Clinical Trial
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL
, 20(10): 811 - 817Sven Nilsson, Alexander Stein, Christian Rolfo, Anne L. Kranich, Julia Mann, Konstantinos Papadimitriou, Susann Theile, Stefanie Amberg and Carsten Bokemeyer*
DOI: 10.2174/1568009620666200628105727
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net